Delivering more for our investors.
Welcome to our Investor Centre. Here you’ll find information about our business, from presentation and analyst reports, ASX announcements, stock information distribution and tax.
ASX
- Loading stock data...
Investor highlights
Offices: Melbourne (Australia)
ASX: AVE (previously traded as Phosphagenics, POH)
TPM® products commercialised under license;
- Voveran® TPM Gel; Novartis, India
- Instanac® TPM Gel; Themis Medicare
- Vital ET® Biofunctional Ingredient; Ashland
- TPM® (for personal care only); Ashland
Investor Resources
Investor Presentations
| Phosphagenics Investor Fact Sheet | 542 KB | |
| Analyst Report NDF Research | 768 KB | |
| Phosphagenics Investor Presentation | 1 MB |
Governance
| Anti-Bribery & Corruption Policy | 195 KB | |
| Securities Trading Policy | 164 KB | |
| Remuneration and Nomination Committee Charter | 206 KB | |
| Audit & Risk Committee Charter | 163 KB | |
| Shareholder Communication Policy | 151 KB | |
| Privacy Policy | 178 KB | |
| Diversity Policy | 156 KB | |
| Continuous Disclosure Policy | 187 KB | |
| Code of Conduct | 179 KB | |
| Board Charter | 211 KB | |
| Whistleblower Policy | 266 KB | |
| Appendix 4G and Corporate Governance Statement | 423 KB |